Search Results - M. S. Zainulina
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
Pathogenetic approach to the treatment of coagulopathic bleeding in obstetrics by T. A. Sushko, M. S. Zainulina
Published 2025-05-01Aim: to justify a differentiated approach to the treatment of obstetric coagulopathic bleeding depending on the nature of hemostasis disorders.Materials and Methods. A prospective cohort study was conducted involving 52 patients with postpartum hemorrhage (PPH) who gave a child birth between 2021 an...
Get full text
Article -
2
Opportunities of using nadroparin calcium for prevention thrombotic complications at risk of coagulopathic bleeding by T. A. Sushko, M. S. Zainulina
Published 2024-01-01An obstetrician-gynecologist faces in clinical practice cases requiring to weigh up not only benefits of administering preventive agents for venous thromboembolic complications (VTEC) but also risks related to concomitant coagulopathy. Here, we discuss issues related to using low molecular weight he...
Get full text
Article -
3
Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation by O. L. Mysik, M. S. Zainulina
Published 2021-05-01Introduction. At present, hemostasis disorders still hold one of the lead places in the pathogenesis of reproductive losses associated with high risk of miscarriage and remain one of the major causes for developing serious obstetric complications. Relevance, efficacy and safety of using drugs contai...
Get full text
Article -
4
THE GOLDEN PAGES IN THE RUSSIAN HISTORY OF OBSTETRICS: FROM THE TIMES OF EKATERINE TO THE PRESENT by A. V. Loginov, M. S. Zainulina
Published 2017-08-01The article is timed to the 245th anniversary of V.F. Snegirev Maternity Hospital № 6 (St. Petersburg). We take an insight into a remarkable story of this Institution from its foundation to the present. Through its history, this maternity hospital was led by outstanding obstetricians who contributed...
Get full text
Article -
5
Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies by D. R. Eremeeva, M. S. Zainulina
Published 2024-09-01Introduction. The role of antiphospholipid antibody (APA) carriage in the pathogenesis of pregnancy failure is one of the most recently debated issues. To date, no unified therapeutic approach to immunotherapy of antiphospholipid syndrome (APS) in pregnancy exists. Intravenous immunoglobulins (IVIG)...
Get full text
Article -
6
Application of the rotational thromboelastography/thromboelastometry for assessment of massive obstetric blood loss in a high risk group by D. R. Eremeeva, M. S. Zainulina
Published 2020-04-01Here, we discuss blood management upon a risk of massive obstetric hemorrhage by describing a clinical case of female patient with obstetric complications of pregnancy such as severe preeclampsia and chronic placental insufficiency with fetal malnutrition examined by using thromboelastometry to asse...
Get full text
Article -
7
Risks of reproductive loss and placenta-mediated pregnancy complications in women with antiphospholipid antibodies by Yu. S. Dolgova, D. R. Eremeeva, M. S. Zainulina
Published 2021-01-01Introduction. Antiphospholipid syndrome (AРS) is a multisystem disease characterized by elevated levels of antiphospholipid antibodies (AРA), arterial and/or venous thrombosis, thrombocytopenia, and habitual miscarriage. Various AРA types have multifactorial and indirect effects on pregnancy course...
Get full text
Article -
8
Complications and outcomes of pregnancy in patients with antiphospholipid antibodies during various treatment methods by Yu. S. Bagdasarova, M. S. Zainulina, M. G. Nikolaeva
Published 2023-05-01Introduction. Antiphospholipid antibodies (APAs) exert multifaceted effects on the course of pregnancy by disrupting microcirculation, affecting the hemostasis, as well as damaging the endothelial membranes, leading to early reproductive loss and development of placenta-associated complications depe...
Get full text
Article -
9
ANTIPHOSPHOLIPID SYNDROME AND EARLY REPRODUCTIVE FAILURE by M. I. Krivonos, M. S. Zainulina, S. A. Selkov
Published 2017-03-01Antiphospholipid antibodies by disrupting trophoblast invasion and endometrial angiogenesis might contribute to a defective placentation and, in turn, affect the successful beginning of pregnancy. It is well known and proven that these processes begin with the founding of the utero-placental blood f...
Get full text
Article -
10
Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome by E. S. Orlova, S. V. Chepanov, M. S. Zainulina, S. A. Selkov
Published 2025-01-01Our objective was to demonstrate the efficiency of therapy for antiphospholipid syndrome (APS) in pregnant women using plasmapheresis and intravenous immunoglobulins.92 women with diagnosed APS and 47 APS-free women with physiological pregnancy were under study. APS was diagnosed in accordance with...
Get full text
Article -
11
MATERNAL MORTALITY AND MATERNAL «NEAR MISS»: ARE THE CURRENT BLEEDING PREVENTION ALGORITHMS WORKING? by M. S. Zainulina, D. R. Eremeeva, M. I. Krivonos
Published 2018-05-01Bleeding during pregnancy, labor and delivery is considered the major cause of maternal death or subsequent disability, and various disorders. Currently, obstetricians and gynecologists have a number of effective tools for the prevention and treatment of obstetrical bleedings. Compliance with the Fe...
Get full text
Article -
12
USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES by M. I. Krivonos, M. S. Zainulina, E. A. Kornyushina, S. V. Chepanov, S. A. Selkov
Published 2017-12-01Introduction. Women with infertility and circulating antiphospholipid antibodies (APA) may be at risk of reproductive losses. A possible way to improve their in vitro fertilization (IVF) outcomes is the immunomodulating therapy using intravenous immunoglobulin (IVIG). Aim: to study the effecacy...
Get full text
Article -
13
What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas? by V. O. Bitsadze, M. S. Zainulina, J. Kh. Khizroeva, M. G. Nikolaeva, A. D. Makatsariya
Published 2023-09-01An issue of venous thromboembolic events (VTEs) in pregnant women and puerperas in Russia as well as throughout the world remains relevant. Specialized events with expert’s participation could not be better to promote active discussion and constructive solution of complex problems, which refer to is...
Get full text
Article -
14
Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype) by M. G. Nikolaeva, A. P. Momot, M. S. Zainulina, K. A. Momot, N. N. Yasafova
Published 2018-08-01The aim of the study was to determine the efficacy of heparin prophylaxis in preventing pregnancy complications in patients with the manifested laboratory phenotype – resistance to activated protein C (APC-resistance with NR ≤ 0.49) Factor V Leiden mutation (GA genotype). Materials and methods. A si...
Get full text
Article -
15
Flow cytofluorimetric detection and immunophenotyping of platelet-monocyte complexes in peripheral blood by O. V. Pavlov, S. V. Chepanov, A. V. Selutin, M. S. Zainulina, D. R. Eremeeva, S. A. Selkov
Published 2021-05-01Activated platelets aggregate with monocytes by binding membrane bound molecules. Platelet-monocyte interaction is considered to underlie pathophysiological mechanisms bridging thrombosis and inflammation. Detection and analysis of platelet-monocyte complexes (PMC) provide means for revealing their...
Get full text
Article -
16
Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies by D. R. Eremeeva, M. S. Zainulina, Yu. S. Dolgova, R. A. Shakhaliev, O. A. Silvanovich, L. A. Pavlova
Published 2021-03-01Aim: to evaluate efficacy of plasmapheresis combined with low molecular weight heparins (LMWH) and acetylsalicylic acid (ASA).Materials and Methods. 327 plasmapheresis sessions were performed for 75 patients: 17 (22.6 %) patients during preparation for pregnancy, 11 (19.0 %) pregnant women in the fi...
Get full text
Article -
17
Gestational complications of the prothrombin G20210A mutation related to prothrombin activity by M. G. Nikolaeva, N. N. Yasafova, A. P. Momot, M. S. Zainulina, K. A. Momot, I. A. Taranenko
Published 2020-07-01Aim: to study the association between prothrombin activity in the blood plasma and gestational complications in women with the prothrombin G20210A mutation.Materials and methods. A prospective clinical cohort study including 290 pregnant women aged 18 to 45 years was conducted from 2012 to 2018. Two...
Get full text
Article -
18
INFLUENCE OF SOLUBLE PLACENTAL TISSUE-DERIVED MOLECULES UPON EXPRESSION OF ADHESION MOLECULES BY EA.HY926 ENDOTHELIAL CELLS by O. I. Stepanova, T. U. Lvova, E. N. Purbeeva, M. I. Mirashvili, M. S. Zainulina, S. A. Selkov, D. I. Sokolov
Published 2014-07-01Abstract. Leukocyte recruitment to placental tissue is an important factor of its development. In this respect, adhesion molecules at the endothelial cell surface represent a key determining factor of leukocyte adhesion and their trans-endothelial migration. The goal of investigation w...
Get full text
Article -
19
EXPRESSION OF SURFACE MARKERS ON CD4+T-LYMPHOCYTES IN NORMAL PREGNANCY AND PRE-ECLAMPSIA by V. A. Mikhailova, Y. S. Onokhina, O. M. Ovchinnikova, M. I. Mirashvili, M. S. Zainulina, S. A. Sel’kov, D. I. Sokolov
Published 2014-07-01Abstract. In course of physiological pregnancy, peripheral blood CD4+T-lymphocytes normally migrate to the uterine decidual tissue. Hence, this study aimed to compare expression profiles of adhesion molecules and chemokine receptors on the surface of CD4+T-lymphocytes from peripheral blood in health...
Get full text
Article -
20
Collection of samples from women at different stages of pregnancy to search for early biomarkers of preterm birth by R. A. Illarionov, O. V. Kosyakova, E. S. Vashukova, N. O. Yurkina, M. O. Bakleicheva, Yu. s. Dolgova, T. A. Sushko, D. R. Eremeeva, M. S. Zainulina, M. I. Yarmolinskaya, O. N. Bespalova, A. S. Glotov
Published 2020-12-01Aim. To create a collection of samples from women at different stages of pregnancy to search for early biomarkers of preterm birth.Material and methods. In order to standardize the sample collection, standard operation procedures have been developed with a step-by-step protocol for each research mem...
Get full text
Article